跳至主要内容
临床试验/NCT06326853
NCT06326853尚未招募不适用

Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models

IRCCS San Raffaele0 个研究点目标入组 200 人开始时间: 2024年7月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
200
主要终点
Rate of patients with BMI greater than 30 with hypothalamic-pituitary pathologies

研究概览

简要总结

The goal of this observational study is to evaluate, retrospectively and prospectively, the effect of different hormonal and neuropeptide dysfunctions on the body composition of patients suffering from hypothalamic-pituitary pathologies, and to evaluate the potential beneficial effect of surgical and medical treatments with agonists and antagonists of hypothalamic neuropeptides, currently available, on the development and treatment of adiposity and negative cross-talk between adiposity and muscle/bone tissue

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Obese patients affected and not by hypothalamic-pituitary diseases

排除标准

  • Minor subjects;
  • Pregnant and/or breastfeeding women;
  • Patients suffering from states of primary and/or acquired immunodeficiencies, and/or serious impairment of general clinical conditions (e.g. metastatic neoplasms; immunosuppressive therapies; worsening/reacerbated/compensated chronic pathologies);
  • Patients unable to understand and sign the Informed Consent.

结局指标

主要结局

Rate of patients with BMI greater than 30 with hypothalamic-pituitary pathologies

时间窗: retrospective and prospective collection of clinical data between 01/01/2021 and 31/12/2026

The study aims to evaluate, retrospectively and prospectively, the effect of different hormonal and neuropeptide dysfunctions on the body composition of patients suffering from hypothalamic-pituitary pathologies

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrea Giustina

Professor of Endocrinology and Metabolism

IRCCS San Raffaele

相似试验